SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001193125-17-156176
Filing Date
2017-05-03
Accepted
2017-05-03 16:01:05
Documents
5
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q/A d391620d10qa.htm 10-Q/A 24528
2 EX-10.1 d391620dex101.htm EX-10.1 369053
3 EX-31.1 d391620dex311.htm EX-31.1 2448
4 EX-31.2 d391620dex312.htm EX-31.2 2326
5 GRAPHIC g391620g0503151835232.jpg GRAPHIC 3360
  Complete submission text file 0001193125-17-156176.txt   404253
Mailing Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102
Business Address 1616 EASTLAKE AVE. E SUITE 310 SEATTLE WA 98102 (206) 682-0645
Immune Design Corp. (Filer) CIK: 0001437786 (see all company filings)

IRS No.: 262007174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q/A | Act: 34 | File No.: 001-36561 | Film No.: 17809030
SIC: 2834 Pharmaceutical Preparations